In agreement with the findings of ISG15 upregulation in diverse tumour cell lines in culture, microarray analyses of human tumour biopsies have revealed enhanced expression of ISG15 in pancreatic adenocarcinoma [14], endometrial cancer [13] and bladder cancer [12], when compared with the respective normal tissues. Here, ISG15 is linked to endometrial cancer.